Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-120032

Chief Scientific Officer acquired 599,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2026-11-12 Grant or award +357,000 1,907,554 D
Kidron Miriam Chief Scientific Officer 2026-11-12 Grant or award +242,000 2,149,554 D
Loading xslF345X06/ownership.xml…